Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
86.59
-4.59 (-5.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
May 17, 2023
The biopharmaceutical company's shares have soared during the past year.
Via
The Motley Fool
3 Growth Stocks to Buy and Hold
May 13, 2023
These three stocks defied the bear market last year.
Via
The Motley Fool
Market Rally Diverges; Google Surges On AI News, Inflation Cools, But Breadth Weak: Weekly Review
May 12, 2023
The Nasdaq hit a new 2023 high, but not the S&P 500 or Dow Jones.
Via
Investor's Business Daily
This Analyst Creates Bullish Pitch For Axsome Therapeutics On Increased Outlook For Its Depression Drug
May 11, 2023
Mizuho increased the price target on Axsome Therapeutics Inc (NASDAQ: AXSM) from $84 to $95 with a Buy rating
Via
Benzinga
Expert Ratings for Axsome Therapeutics
May 09, 2023
Via
Benzinga
Earnings Outlook For Axsome Therapeutics
May 05, 2023
Via
Benzinga
Axsome Therapeutics Stock: Bear vs. Bull
April 23, 2023
Axsome shares beat the bear market last year.
Via
The Motley Fool
2 Beaten-Down Growth Stocks to Buy in April
April 20, 2023
These companies have lucrative opportunities ahead.
Via
The Motley Fool
2 Magnificent Growth Stocks You Can Buy With $150 Right Now
May 10, 2023
You don't have to wait until you're rich to start getting your money to work for you.
Via
The Motley Fool
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
May 09, 2023
The biotech's share price more than doubled during last year's bear market.
Via
The Motley Fool
Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression Drug Sees Improved Coverage
May 08, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q1 revenue of $94.6 million, consisting of net product sales of $28.6 million, license revenue of $65.7 million, and
Via
Benzinga
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
May 08, 2023
AXSM earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite.
May 08, 2023
Axsome shares are nearing a breakout point. But BioXcel crumbled on its report.
Via
Investor's Business Daily
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
May 08, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Could Axsome Therapeutics Stock Help You Become a Millionaire?
April 16, 2023
In the past five years, the stock has risen by nearly 2,400%.
Via
The Motley Fool
Is It Too Late to Buy Axsome Therapeutics Stock?
April 15, 2023
With two major catalysts in the rearview mirror, it's easy to think that it's too late.
Via
The Motley Fool
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month
May 01, 2023
One World Trade Center to be lit up in green in observance of Mental Health Month
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
April 28, 2023
Here are three biotech stocks with promising innovations that could provide catalysts for their respective stocks in 2023
Via
InvestorPlace
NASDAQ: AXSM Shareholder Notice: Investigation over Potential Wrongdoing at Axsome Therapeutics, Inc.
April 27, 2023
San Diego, CA -- (SBWIRE) -- 04/27/2023 -- Certain directors of Axsome Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
April 25, 2023
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.
Via
InvestorPlace
If You Invested $5,000 in Axsome Therapeutics 5 Years Ago, Here's How Much You Would Have Now
April 25, 2023
Axsome's new products have blockbuster potential.
Via
The Motley Fool
3 Stocks With Huge Catalysts on the Way
April 22, 2023
Big news could mean big boosts for these stocks.
Via
The Motley Fool
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of
April 21, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The Top 3 Biotech Stocks to Watch in 2023
April 20, 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.
Via
InvestorPlace
1 Risky Growth Stock Wall Street Says Is Poised for a 47% Rally
April 20, 2023
Its price should keep rising, but perhaps Wall Street is a bit enthusiastic with its forecasts.
Via
The Motley Fool
The Top Healthcare Stocks to Buy With $100
April 18, 2023
A small investment now may bring big results over time.
Via
The Motley Fool
Better Growth Stock: Axsome vs. CRISPR Therapeutics
April 16, 2023
These companies are both in the early days of their growth stories.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 14, 2023
Via
Benzinga
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 14, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.